1. 2012 American College of Rheumatology guidelines for the management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricaemia;Khanna;Arthritis Care Res,2012
2. Febuxostat compared with allopurinol in patients with hyperuricaemia and gout;Becker;N Engl J Med,2005
3. Impaired response or insufficient dosage? Examining the potential causes of “inadequate response” to allopurinol in the treatment of gout;Stamp;Semin Arthritis Rheum,2014
4. Plasma oxypurinol as a measure of adherence in clinical trials;Stamp;Ann Rheum Dis,2018
5. A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout;Stamp;Ann Rheum Dis,2017